Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

RADNOR, Pa., Jan. 29, 2024 -- Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other...

Related Keywords

Radnor ,Pennsylvania ,United States ,New York ,Tom Weible ,Catalys Pacific ,Jon Congleton ,Globenewswire Inc ,Elixir Health Public Relations ,Twitter ,Nasdaq ,Mineralys Therapeutics Inc ,Chief Executive Officer ,York City ,Investor Relations ,Mineralys Therapeutics ,